Antiparasitic Drugs Market Size Worth US$ 10,842.7 Million with 5.2% CAGR By 2028 | Ipca Laboratories Ltd., Zydus Cadila, Merck KGaA, Pfizer,

Antiparasitic drugs are medicine that are used in the treatment of parasitic infectious diseases.  Anthelmintics, antiporozoals, and others agents are some of the antiparasitic drug.

According WHO estimation in March 2020, parasitic disease affects 1.5 billion people globally. These diseases include gastrointestinal problems, anemia, wasting, and cognitive and growth deficits in children, and others infections. Among all 1.5 billion people affected with parasitic infectious disease, 24% people are infected with soil-transmitted helminth infections worldwide.

The global antiparasitic drugs market was valued at US$ 7,227.9 million in 2019 and is expected to exhibit a CAGR of 5.2% during the forecast period (2020–2027).

𝐓𝐨 𝐠𝐞𝐭 𝐌𝐨𝐫𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 @ https://www.coherentmarketinsights.com/insight/request-sample/3782

The growing research and development of novel treatments is expected to drive the market growth.

Researchers are focusing on the development of the novel treatments for rare parasitic diseases is driving market growth. For instance, in December 2019, researchers from the University Of Maryland School Of Medicine announced that they have developed a novel treatment for lymphatic filariasis, a disabling parasitic disease that is difficult to treat. The novel treatment has been developed using innovative RNA sequencing techniques. According to the University Of Maryland School Of Medicine, lymphatic filariasis affects over 120 million people worldwide, and it is more prevalent in Asia, Western Pacific, Africa, and parts of the Caribbean and South America. Such factors are driving the growth of the antiparasitic drugs market.

Side effects and risks associated with anti-malaria drugs is projected to hinder the global antiparasitic drugs market growth

Most of the antiparasitic drugs cause severe side effects which is projected to hinder demand for these drugs. For instance, Nifurtimox, a drug or the treatment of Chagas’ disease, may not be effective if taken for long courses. Some other disadvantages such as drug resistance, adverse effects, and higher cost of antimalarial drugs such as chloroquine, sulphadoxine/pyrimethamine, mefloquine, and others is expected to hamper the growth of the antiparasitic drugs market.

𝐆𝐞𝐭 𝐐𝐮𝐢𝐜𝐤 𝐀𝐜𝐜𝐞𝐬𝐬 𝐓𝐨 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 @ https://www.coherentmarketinsights.com/insight/request-pdf/3782

Global Antiparasitic Drugs Market- Regional Analysis

On the basis of region, the global antiparasitic drugs market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Among regions, Africa is projected to hold a leading position in the market, due to growing risk of malaria in the region. For instance, according to the WHO, around 92% of malaria cases in the world occur in Sub-Saharan Africa. In 2017, the WHO also estimated that among the five countries which accounted for nearly half of all malaria cases worldwide, four countries were from Africa region including Nigeria (25%), Democratic Republic of Congo (11%), Mozambique (5%), and Uganda (4%).

In addition to Asia Pacific and Africa, some areas of North America are affected with parasitic infectious diseases. For instance, according to the Centers for Disease Control and Prevention, in 2014, more than 300,000 people in the U.S were infected with Trypanosoma cruzi, the parasite that causes Chagas disease. Moreover, every year, around 300 babies with Trypanosoma Cruzi are born in the U.S. Also, every year, 1,000 hospitalizations for symptomatic cysticercosis occur in the U.S. Furthermore, according to CDC, five neglected parasitic infections (NPIs) including Chagas disease, cysticercosis, toxocariasis, toxoplasmosis, and trichomoniasis are more common in the U.S. Thus, the rising burden of the parasitic infection among the U.S. population is expected to drive growth of the North America antiparasitic drugs market.

Global Antiparasitic Drugs Market – Competitive Landscape

Key players operating in the global antiparasitic drugs market include Ipca Laboratories Ltd., Zydus Cadila, Merck KGaA, Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG, Alvizia Health Care, Bayer AG, Roche Inc., Arbor Pharmaceuticals Inc., Sanofi, AstraZeneca plc., and Alkem Laboratories Limited.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐅𝐅 @ https://www.coherentmarketinsights.com/promo/buynow/3782

Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Overview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Drug Class
     • Market Snippet, By Route of Administration
     • Market Snippet, By Distribution Channel
     • Market Snippet, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Market Trends
   • Key Developments
   • Mergers and Acquisitions
   • Pipeline Analysis
   • Regulatory Scenario
   • Reimbursement Scenario
   • PEST Analysis
4. Global Antiparasitic Drugs Market, By Drug Class, 2016 – 2027, (US$ Million)
   • Introduction
     • Market Share Analysis, 2020 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017 – 2027
     • Segment Trends
   • Anthelmintics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
     • Benzimidazoles
       • Introduction
       • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
     • Pyrantel
       • Introduction
       • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
     • Niclosamide
       • Introduction
       • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
     • Praziquantel
       • Introduction
       • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
     • Others
       • Introduction
       • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
   • Antiprotozoals
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
       • Antimalarial Drugs
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
           1. Aminoquinolines
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
           2. Quinoline-methanol (4-quinolinemethanols)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
           3. Cinchona Alkaloids
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
           4. Biguanides
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million) Corticosteroids
           5. Sulfonamides and sulfones
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
           6. Others
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
         • Other Antiprotozoal Agents
           • • Introduction
             • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
       • Others (Ectoparasites, Pediculocides & miticulocides)
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
       • Lindane
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
       • Malathion
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
       • Pyrethrins
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
       • Others
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
5. Global Antiparasitic Drugs Market, By Route of Administration, 2016 – 2027, (US$ Million)
   • Introduction
     • Market Share Analysis, 2020 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017 – 2027
     • Segment Trends
   • Oral
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
   • Injectable
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
   • Topical
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
6. Global Antiparasitic Drugs Market, By Distribution Channel, 2016 – 2027, (US$ Million)
   • Introduction
     • Market Share Analysis, 2020 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017 – 2027
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)

View Press Release: https://www.coherentmarketinsights.com/press-release/antiparasitic-drugs-market-3048

About US:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837